Search Results for 'Asco 2014'

Asco 2014 published presentations and documents on DocSlides.

DISCOVER THE AWESOME POWER OF THE ASCO LOW VOLTAGE 7000 SERIES GENERA

DISCOVER THE AWESOME POWER OF THE ASCO LOW VOLTAGE 7000 SERIES GENERA

by conchita-marotz

The ASCO 7000 ERIES Generator Paralleling Control...

Advances in the Immunotherapy of Solid Tumors

Advances in the Immunotherapy of Solid Tumors

by myesha-ticknor

Malignant Melanoma. (8 minutes). Antoni Ribas, M....

by phoebe-click

. Highlights from the Annual Clinical Meeting. G...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Genetic plasma cell signatures in high-risk smoldering myel

Genetic plasma cell signatures in high-risk smoldering myel

by trish-goza

Presented By Sham Mailankody at 2016 ASCO Annual ...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final

Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final

by thegagn

Presented By Lorenz Trumper at 2016 ASCO Annual Me...

CONKO-007: Chemoradiotherapy vs

CONKO-007: Chemoradiotherapy vs

by davies

Chemotherapy Alone for Unresectable . Locally Adva...

Meeting summary ASCO GU 2020,

Meeting summary ASCO GU 2020,

by patricia

San Francisco. , USA. Assoc. . Prof. . Shilpa Gupt...

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

by hadley

Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...

Membership Application Every Oncology Professional Everywhere Should be an ASCO Member

Membership Application Every Oncology Professional Everywhere Should be an ASCO Member

by min-jolicoeur

EXPERIENCE THE VALUE OF ASCOS GLOBAL COMMUNITY Th...

Understanding Bubbly Episodes By ASCO M

Understanding Bubbly Episodes By ASCO M

by alexa-scheidler

C ARVALHO A LBERTO ARTIN AND AUME ENTURA Wealth ...

asco This playset is an accessory for the Fiasco role

asco This playset is an accessory for the Fiasco role

by giovanna-bartolotta

This playset is copyright 2013 by James DAmato Fi...

ASCO 388, 390, and 401 Series are 2-Way, normally closed and normally

ASCO 388, 390, and 401 Series are 2-Way, normally closed and normally

by alexa-scheidler

32

Assessment for hereditary colorectal cancer

Assessment for hereditary colorectal cancer

by yoshiko-marsland

Kalyani Maganti, M.D. ASCO. Chromosomes, DNA, and...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

by debby-jeon

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

by mitsue-stanley

Myeloproliferative. Neoplasms. January 20, 2012....

ASCO Update 2012:

ASCO Update 2012:

by tatyana-admore

Gastrointestinal Malignancies. Thomas J. Semrad M...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

by debby-jeon

Year in Review 2012. Colorectal Cancer. Daniel G ...

by liane-varnes

in . Uganda. By. : Andrea . Goetzke. . http://ww...

by liane-varnes

CO 2 Vaporising The ASCO 2 Vaporiser has been ...

The CREST Trial

The CREST Trial

by kittie-lecroy

Presented By James Hill at 2016 ASCO Annual Meeti...

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

Going to the Gulf Our Experience in Qatar

Going to the Gulf Our Experience in Qatar

by alexa-scheidler

Sam Murdock – Director of Water Services. Enter...

Primer on Kinase Inhibitors

Primer on Kinase Inhibitors

by giovanna-bartolotta

Richard R. Furman. Directory, CLL Research Center...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

by danika-pritchard

ASCO-CAP Recommendations For HER2 Testing in Brea...

Ezra W Cohen University of California, San Diego

Ezra W Cohen University of California, San Diego

by natalia-silvester

Ezra W Cohen University of California, San Diego...

ASCO 2019 NSCLC - PARP & Chemotherapy

ASCO 2019 NSCLC - PARP & Chemotherapy

by mitsue-stanley

ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...

Ovarian cancer with update from ASCO 2013

Ovarian cancer with update from ASCO 2013

by karlyn-bohler

Siew. . wei. . wong. Oncology registrar. Epidem...

Best of ASCO GU Session Sandy Srinivas.MD

Best of ASCO GU Session Sandy Srinivas.MD

by experimentgoogle

Stanford University. Outline. Abstract #4. :. . I...

Behandeling van het recidief ovariumcarcinoom

Behandeling van het recidief ovariumcarcinoom

by sandsomber

Ignace Vergote MD PhD FACS FSPS. Chairman, Leuven ...

ASCO 2012 Review Gynecologic Cancer

ASCO 2012 Review Gynecologic Cancer

by welnews

Nelson Teng, M.D., Ph.D.. Director, Gynecologic On...

Immunotherapy – the good news and the bad

Immunotherapy – the good news and the bad

by warlikebikers

Associate Professor Philip Beale. Chair ANZGOG Cli...

Immunotherapy – the good news and the bad

Immunotherapy – the good news and the bad

by medshair

Associate Professor Philip Beale. Chair ANZGOG Cli...

Presented at the American Society of Clinical Oncology ASCO Annual Mee

Presented at the American Society of Clinical Oncology ASCO Annual Mee

by eliza

8 2021Patientswithhigh-doselymphodepletionCohort2w...

Jchem applications in Medchem

Jchem applications in Medchem

by StarsAndStripes

Prediction. . and. . Data Sorting. Zhengtao. Li...

mCODE Community of Practice Monthly Meeting

mCODE Community of Practice Monthly Meeting

by jocelyn

Chairs – Rob Dingwell & Zeshan Rajput. Suppo...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

by lily

Senior Investigator, . Breast Cancer Research. Ten...

Updates in the systemic treatment for lung

Updates in the systemic treatment for lung

by madeline

cancer: Immunotherapy. Oscar Arrieta MD. Thoracic....

TRK fusion-positive cancer highlights from ASCO 2022

TRK fusion-positive cancer highlights from ASCO 2022

by joanne

Prof. David S. Hong. Medical Oncologist. MD Anders...